Policy Comments

The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.

    Letter to HHS supporting Delaware’s decision to reinstate retroactive coverage for all Medicaid beneficiaries.

    Medicaid Section 1115 Waivers, Medicare, Medicaid, and Private Health Insurance Coverage

    Letter urging HHS to approve the requests for inclusion of continuous eligibility for parent and caretaker relatives (12 months), and for children aging out of the Children’s Health Insurance Program (CHIP) to improve health equity among other outcomes.

    Medicaid Section 1115 Waivers, Medicare, Medicaid, and Private Health Insurance Coverage

    Letter opposing the Oklahoma’s continued waiver of three-month retroactive coverage. Retroactive coverage prevents gaps in coverage by allowing individuals who are eligible for Medicaid to begin treatment prior to officially receiving their coverage determination.

    Medicaid Section 1115 Waivers, Medicare, Medicaid, and Private Health Insurance Coverage

    Letter to HHS supporting Rhode Island's request for pre-release services for justice-involved populations, supporting expanded postpartum coverage, and opposing the continued waiver of retroactive coverage.

    Medicaid Section 1115 Waivers, Medicare, Medicaid, and Private Health Insurance Coverage

    Letter thanking the original House sponsors of the HELP Copays Act (H.R. 830) and pledging support to help pass the bill.

    Access to Affordable, Comprehensive Care, Copay Accumulators, Utilization Management

    Letter to CMS in response to the Contract Year 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs proposed rule that addresses expanded eligibility for low-income subsidy benefit under Part D, making the Limited Income New Eligible Transition demonstration permanent, changing the Medical Therapy Management program, aligning Part C and Part D Special Enrollment Periods with Medicare exceptional condition enrollment, and failure to collect and incorrect collections of Part D premiums and cost-sharing amounts.

    Medicare, Medicaid, and Private Health Insurance Coverage

    Letter to all members of the 118th Congress to introduce the Partnership to Protect Coverage Coalition and the priorities for the 118th Congress. These priorities include protecting Medicaid, closing the coverage gap, promoting affordability of coverage, removing barriers to accessing care, and more.

    Medicare, Medicaid, and Private Health Insurance Coverage

    Letter to HHS in support of New Mexico's efforts to expand access to quality, affordable coverage and urging approval of the requests to expand continuous eligibility for children under 6 and pre-release coverage for justice-involved populations.

    Medicaid Section 1115 Waivers, Medicare, Medicaid, and Private Health Insurance Coverage

    Letter in response to CMS' request for information on the essential health benefits (EHBs) in the Affordable Care Act focusing on people with cancer and revisions to EHBs to ensure their access to quality cancer care.

    Affordable Care Act, Medicare, Medicaid, and Private Health Insurance Coverage

    Letter in response to the Notice of Benefit Payment Parameters for 2024 that addresses network adequacy, prohibiting mid-year termination for dependent children who turn 26, special enrollment periods, standardized plan options, and drugs classified as "non-essential" health benefits.

    Medicare, Medicaid, and Private Health Insurance Coverage